COMMUNIQUÉS West-GlobeNewswire

ObsEva SA Announces $75 Million Credit Facility with Oxford Finance LLC
07/08/2019
Geneva, Switzerland and Boston, MA – August 7, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]
ObsEva Reports Second Quarter 2019 Financial Results
07/08/2019
Multiple Major Milestones Expected This Year - Q4:19 Phase 3 data for IMPLANT 4 trial of nolasiban - Nolasiban MAA submission targeted for year- end 2019 - Q4:19 Phase 3 data for PRIMROSE 2 trial of linzagolix in [...]
Allakos Announces Upsizing and Pricing of Public Offering of Common Stock
07/08/2019
REDWOOD CITY, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing AK002 for the treatment of eosinophil and mast cell related diseases, today [...]
Opthea Meets Primary Endpoint in Phase 2b Study of OPT-302 in Wet AMD
07/08/2019
OPT-302 Combination Therapy Demonstrated Superiority in Visual Acuity over Lucentis ® Company to Host Conference Call Today at 9:00 AM AEST 7:00PM EDT (Tuesday, August 6th U.S) -Dial-in details posted at end of release [...]
Novartis stands behind Zolgensma® (onasemnogene abeparvovec-xioi) for the treatment of children less than 2 years of age with spinal muscular atrophy
07/08/2019
Basel, August 6, 2019 – Today the FDA released a statement addressing data integrity issues with the Biologics License Application (BLA) for Zolgensma® (onasemnogene abeparvovec-xioi). First and foremost, we are fully [...]
Melinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results Reporting
06/08/2019
~ Second Quarter 2019 Financial Results to be Reported on Friday, August 9, 2019 ~ ~ Company Cancels Previously Scheduled Earnings Call ~ MORRISTOWN, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. ( [...]
National Research Corporation Announces Second Quarter 2019 Results
06/08/2019
LINCOLN, Neb., Aug. 06, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced results for the second quarter of 2019. Net New Sales of $6.1 million up 14% Revenue increased 12% to $31.4 [...]
Supernus Announces Second Quarter 2019 Financial Results
06/08/2019
Total revenue of $104.7 million, a 5.2% increase over 2018 Net product sales of $102.4 million, a 5.5% increase over 2018 Operating earnings of $42.6 million, a 19.3% increase over 2018 Submission of New Drug [...]
Clearside Biomedical to Present at the 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
ALPHARETTA, Ga., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Denali Therapeutics Reports Second Quarter 2019 Financial Results and Business Highlights
06/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative diseases, [...]
Silk Road Medical Announces Proposed Public Offering of Common Stock
06/08/2019
SUNNYVALE, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, announced today the [...]
Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock and Convertible Senior Notes
06/08/2019
Source: Mesa Laboratories, Inc. – August 6, 2019 4:05 PM ET LAKEWOOD, Colo., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced that it has commenced concurrent [...]
Zafgen to Present at the Wedbush PacGrow Healthcare Conference
06/08/2019
BOSTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Dova Pharmaceuticals to Present at 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
DURHAM, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Jason Hoitt, Chief Commercial Officer, will present a company overview at the 2019 Wedbush PacGrow [...]
Editas Medicine Announces Second Quarter 2019 Results and Update
06/08/2019
Cynthia (Cindy) Collins named President and Chief Executive Officer Initiated Brilliance Phase 1/2 clinical trial of EDIT-101(AGN-151587) for LCA10 Patient dosing in Brilliance trial on track for 2H19 EDIT-301 for [...]
The Cooper Companies to Participate in the Baird Healthcare Conference
06/08/2019
PLEASANTON, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the Baird 2019 Global Healthcare Conference in New York, NY, on September 4, 2019. Albert G. White III, [...]
Inspire Medical Systems, Inc. Announces Second Quarter 2019 Financial Results and Increases 2019 Outlook
06/08/2019
MINNEAPOLIS, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Alder BioPharmaceuticals® Reports Second Quarter 2019 Financial and Operating Results
06/08/2019
Data presented at American Academy of Neurology and American Headache Society Annual Meetings continue to support eptinezumab’s differentiated clinical profile and impact on quality of life measures Core commercial [...]
Healthcare Veteran Kristine Johnson to Join MRI Interventions' Board of Directors
06/08/2019
IRVINE, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC) is pleased to announce that B. Kristine Johnson has been appointed to MRI Interventions’ Board of Directors, effective [...]

Pages